Want to join the conversation?
$LLY said its new products generated $428MM in revenue in 2Q16 led by Trulicity and Cyramza. This represents 8% of total worldwide revenue. The company reduced Opex as a percent of revenue versus 2Q15 and remains on track for a full-year 2016 reduction of 200-250BP.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?